These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 27114332

  • 1. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.
    Bar-Hava I, Mizrachi Y, Karfunkel-Doron D, Omer Y, Sheena L, Carmon N, Ben-David G.
    Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332
    [Abstract] [Full Text] [Related]

  • 2. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S, Blockeel C, Tremellen KP, Fleming R, Tournaye H, Humaidan P, Nelson SM.
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [Abstract] [Full Text] [Related]

  • 3. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY.
    Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
    [Abstract] [Full Text] [Related]

  • 4. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
    Martínez F, Rodríguez DB, Buxaderas R, Tur R, Mancini F, Coroleu B.
    Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
    [Abstract] [Full Text] [Related]

  • 5. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN, Ho MT, Ha TD, Phung HT, Huynh GB, Humaidan P.
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [Abstract] [Full Text] [Related]

  • 6. HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept.
    Haas J, Kedem A, Machtinger R, Dar S, Hourvitz A, Yerushalmi G, Orvieto R.
    J Ovarian Res; 2014 Apr 03; 7():35. PubMed ID: 24694069
    [Abstract] [Full Text] [Related]

  • 7. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N, Ceran MU, Ugurlu EN, Gülerman HC, Engin Ustun Y.
    J Obstet Gynaecol; 2020 Aug 03; 40(6):837-842. PubMed ID: 31791167
    [Abstract] [Full Text] [Related]

  • 8. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
    Huber M, Hadziosmanovic N, Berglund L, Holte J.
    Fertil Steril; 2013 Nov 03; 100(5):1270-6. PubMed ID: 23931964
    [Abstract] [Full Text] [Related]

  • 9. Gonadotropin-releasing hormone agonist (GnRHa) trigger - State of the art.
    Dosouto C, Haahr T, Humaidan P.
    Reprod Biol; 2017 Mar 03; 17(1):1-8. PubMed ID: 28215488
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY, Elbaek HO, Alsbjerg B, Laursen RJ, Povlsen BB, Thomsen L, Humaidan P.
    Hum Reprod; 2015 Oct 03; 30(10):2387-95. PubMed ID: 26209535
    [Abstract] [Full Text] [Related]

  • 12. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C.
    Fertil Steril; 2008 Jan 03; 89(1):84-91. PubMed ID: 17462639
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.
    Atkinson P, Koch J, Ledger WL.
    Aust N Z J Obstet Gynaecol; 2014 Dec 03; 54(6):581-5. PubMed ID: 25476811
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.